The synthesis and SAR of calcitonin gene-related peptide (CGRP) receptor antagonists derived from tyrosine surrogates. Part 2

9Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Various substituted indazole and benzoxazolone amino acids were investigated as d-tyrosine surrogates in highly potent CGRP receptor antagonists. Compound 3, derived from the 7-methylindazole core, afforded a 30-fold increase in CGRP binding potency compared with its unsubstituted indazole analog 1. When dosed at 0.03 mg/kg SC, compound 2 (a racemic mixture of 3 and its (S)-enantiomer) demonstrated robust inhibition of CGRP-induced increases in mamoset facial blood flow up to 105 min. The compound possesses a favorable predictive in vitro toxicology profile, and good aqueous solubility. When dosed as a nasal spray in rabbits, 3 was rapidly absorbed and showed good intranasal bioavailability (42%). © 2013 Elsevier Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Han, X., Civiello, R. L., Conway, C. M., Cook, D. A., Davis, C. D., Degnan, A. P., … Dubowchik, G. M. (2013). The synthesis and SAR of calcitonin gene-related peptide (CGRP) receptor antagonists derived from tyrosine surrogates. Part 2. Bioorganic and Medicinal Chemistry Letters, 23(6), 1870–1873. https://doi.org/10.1016/j.bmcl.2013.01.011

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free